Trade CRBP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is trading at US$5.27, down 2.04% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$200.76M. Over the past 52 weeks, CRBP has traded between US$5.11 and US$20.56. On Syfe you can trade CRBP with $0 commission and add it to your watchlist.
| Previous close | US$5.38 |
|---|---|
| Market cap | US$200.76M |
| 52-week range | US$5.11 – US$20.56 |
| Volume | 1.01M |
| Exchange | US |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Year: 2014
Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating
Aug 13, 9:22 AM · MT Newswires
Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating
Aug 7, 1:18 PM · MT Newswires
Corbus Pharmaceuticals Completes Patient Visits in Phase 1b Obesity Study
Aug 4, 4:25 PM · MT Newswires
Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating
Jun 23, 2:03 PM · MT Newswires
Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating
Jun 17, 12:31 PM · MT Newswires
Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is trading at US$5.27, -2.04% from the previous close of US$5.38.
The market cap for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is approximately US$200.76M.
The 52-week high for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is US$20.56.
The 52-week low for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is US$5.11.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) does not currently pay a dividend.
Stay on top of CRBP
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
